Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21
Takeshi Inagaki, Paul A. Dutchak, Guixiang Zhao et al. · Cell Metabolism · 2007
Cited by 1,500 works. doi:10.1016/j.cmet.2007.05.003 Open-access PDF
Authors
- Takeshi Inagaki
- Paul A. Dutchak
- Guixiang Zhao
- Xunshan Ding
- Vinay Parameswara
- Yong Li
- Regina M. Goetz
- Moosa Mohammadi
- Victoria Esser
- Joel Keith Elmquist
- Robert D. Gerard
- Shawn C. Burgess
- Robert E. Hammer
- David J. Mangelsdorf
- Steven A. Kliewer
References
- A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
- Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
- The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.
- FGF-21 as a novel metabolic regulator
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
- Roles of PPARs in health and disease
- Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes.
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
- Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States
- A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders